New Formula & New Presentation
 |
 |
Years of Experience Active & with Vitality
Androcell 2G
The effect of Androcell 2G on sexual desire and the lack of relationship to serum testosterone levels in healthy adult males.
Clinical Study
This study took place over a period of 12 weeks, with a parallel trial, using the randomised controlled double blind method, in which treatment with different doses of Androcell 2G was compared to the placebo. This study wished to demonstrate whether the effect of Androcell 2G on the subjective report was related to effects on humour and serum testosterone levels.Males between 45 and 55 years of age received Androcell 2G on one of two doses: 1000 mg or 3000 mg; or placebo. Personal perception regarding sexual desire, as well as the results of the Hamilton depression scale and the Hamilton anxiety scale, were evaluated at 4, 8 and 12 weeks of treatment. An improvement in sexual desire was detected at 8 weeks of treatment. There was no difference in the levels of serum testosterone and oestradiol in males treated with Androcell 2G and those treated with a placebo (P=NS).
The logistic regression analysis showed that Androcell 2G has an independent effect on sexual desire at 8 and at 12 weeks of treatment and that these changes are not owing to the results of the Hamilton depression and anxiety scales or to the serum testosterone and oestradiol levels. In conclusión, treatment with Androcell 2G increases sexual desire.
Effect of Androcell 2G on increased fertility and on reproductive hormone levels in helathy adult males. This parallel trial, double blind, placebo-controlled study, in which active treatment was carried out with different doses of Androcell 2G, was compared with the placebo. The objective of the study was to prove the effectiveness that the Androcell 2G organic biofactor has on serum reproductive hormone levels in apparently healthy males, when it is administered in doses used for therapeutic purposes to increase fertility. Males between 45 and 55 years of age received 1000 mg or 3000 mg of Androcell 2G. The serum levels of luteinising hormone, the hormone that stimulates the follicles, prolactin, 17-alpha hydroxy progesterone, testosterone and 17-beta oestradiol, were measured before and after 2, 4, 8 and 12 weeks of treatment with a placebo and with Androcell 2G. The results data showed that Androcell 2G had a significant increase over the minimum and maximum references of the hormones studied and that low testosterone levels increase. The multiple regression analysis showed that serum testosterone levels were affected by treatment with Androcell 2G; as of the fourth week of the study, changes began to be noticed in comparison to the individuals who did not receive the treatment. In conclusion, treatment with Androcell 2G increases serum reproductive hormone levels.
